Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
Department of Computer Science, Aalto University School of Science, Espoo, Finland.
Diabetes. 2019 Oct;68(10):2024-2034. doi: 10.2337/db19-0287. Epub 2019 Jul 16.
The appearance of type 1 diabetes (T1D)-associated autoantibodies is the first and only measurable parameter to predict progression toward T1D in genetically susceptible individuals. However, autoantibodies indicate an active autoimmune reaction, wherein the immune tolerance is already broken. Therefore, there is a clear and urgent need for new biomarkers that predict the onset of the autoimmune reaction preceding autoantibody positivity or reflect progressive β-cell destruction. Here we report the mRNA sequencing-based analysis of 306 samples including fractionated samples of CD4 and CD8 T cells as well as CD4CD8 cell fractions and unfractionated peripheral blood mononuclear cell samples longitudinally collected from seven children who developed β-cell autoimmunity (case subjects) at a young age and matched control subjects. We identified transcripts, including interleukin 32 (), that were upregulated before T1D-associated autoantibodies appeared. Single-cell RNA sequencing studies revealed that high in case samples was contributed mainly by activated T cells and NK cells. Further, we showed that expression can be induced by a virus and cytokines in pancreatic islets and β-cells, respectively. The results provide a basis for early detection of aberrations in the immune system function before T1D and suggest a potential role for IL32 in the pathogenesis of T1D.
1 型糖尿病(T1D)相关自身抗体的出现是预测遗传易感个体向 T1D 进展的第一个也是唯一可衡量的参数。然而,自身抗体表明存在活跃的自身免疫反应,其中免疫耐受已经被打破。因此,迫切需要新的生物标志物来预测自身抗体阳性之前的自身免疫反应的发作或反映进行性β细胞破坏。在这里,我们报告了基于 mRNA 测序的分析,该分析涉及 306 个样本,包括从 7 名年轻时发生β细胞自身免疫(病例组)的儿童以及匹配的对照对象中纵向收集的 CD4 和 CD8 T 细胞以及 CD4CD8 细胞部分的分馏样本和未分馏的外周血单核细胞样本。我们鉴定了转录本,包括白细胞介素 32 (),其在出现 T1D 相关自身抗体之前上调。单细胞 RNA 测序研究表明,高 在病例样本中主要由活化的 T 细胞和 NK 细胞贡献。此外,我们表明, 表达可以分别由病毒和细胞因子在胰岛和β细胞中诱导。这些结果为 T1D 之前免疫系统功能异常的早期检测提供了依据,并提示 IL32 在 T1D 发病机制中的潜在作用。